Pharmatrade
Pharmatrade, a leading name in the pharmaceutical distribution sector, is headquartered in the United Arab Emirates (AE) and operates extensively across the Middle East. Founded in 2001, the company has established itself as a key player in the industry, focusing on the distribution of high-quality pharmaceutical products, medical devices, and healthcare solutions. With a commitment to excellence, Pharmatrade offers a diverse range of services, including logistics and supply chain management, ensuring timely delivery of essential healthcare products. Their unique approach combines innovative technology with a deep understanding of market needs, positioning them as a trusted partner for healthcare providers. Notable achievements include strategic partnerships with renowned global manufacturers, solidifying their market position and enhancing their reputation for reliability and quality in the pharmaceutical landscape.
DitchCarbon Score
How does Pharmatrade's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Health Services industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Pharmatrade's score of 2 is lower than 86% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Pharmatrade's reported carbon emissions
In 2022, Pharmatrade reported total carbon emissions of approximately 47743000 kg CO2e from Scope 1 and about 287102000 kg CO2e from Scope 2. This reflects a slight decrease in Scope 1 emissions from about 52862000 kg CO2e in 2021, indicating a commitment to reducing direct emissions. However, Scope 2 emissions saw a marginal increase from approximately 284807000 kg CO2e in the previous year. Pharmatrade has not disclosed any specific reduction targets or initiatives under the Science Based Targets initiative (SBTi) or other climate pledges, suggesting a need for further commitment in this area. The company operates within a global context where many organisations are increasingly focusing on comprehensive climate strategies to mitigate their environmental impact.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
Add to project| 2021 | 2022 | |
|---|---|---|
| Scope 1 | 52,862,000 | 00,000,000 |
| Scope 2 | 284,807,000 | 000,000,000 |
| Scope 3 | - | - |
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Pharmatrade is not committed to any reduction initiatives we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
